首页> 外文期刊>Hematological oncology >Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
【24h】

Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.

机译:外周T细胞淋巴瘤,未指定(或未另外指定):综述。

获取原文
获取原文并翻译 | 示例
           

摘要

Peripheral T-cell lymphomas (PTCL) comprises a heterogeneous group of haematological tumours, which originate from mature T-cells, and constitute less than 15% of all non-Hodgkin's lymphomas (NHLs) in adults. The current WHO classification recognizes nine distinct clinicopathologic peripheral T-cell NHLs, being the 'unspecified variant' (PTCL-U) the most common subtype. These neoplasms often present in advanced stage at diagnosis, and most commonly have an aggressive clinical course requiring prompt treatment. The rarity of these tumours requires additional studies to better understand their biology and search for new therapies which may hopefully improve the dismal outcome of most patients. This review aims to describe the pathobiological aspects as well the clinical characteristics and current therapeutic strategies of the PTCLs, with special attention to the group of PTCL-U.
机译:外周血T细胞淋巴瘤(PTCL)包括异种血液肿瘤,起源于成熟的T细胞,占成年人非霍奇金淋巴瘤(NHL)的不到15%。当前的WHO分类标准可识别9种不同的临床病理学外周T细胞NHL,它们是最常见的亚型“未指定变体”(PTCL-U)。这些肿瘤通常在诊断时处于晚期,最常见的是侵袭性临床病程,需要及时治疗。这些肿瘤的稀有性需要进行更多的研究,以更好地了解其生物学特性并寻找新的疗法,从而有望改善大多数患者的悲惨结局。这篇综述旨在描述PTCL的病理生物学方面以及临床特征和当前的治疗策略,并特别注意PTCL-U组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号